The following pages link to magaldrate (Q419991):

Displaying 29 items.

• peptic ulcer disease (Q172941) (← links)
• gastroesophageal reflux disease (Q223591) (← links)
• duodenal ulcer (Q355170) (← links)
• heartburn (Q537297) (← links)
• indigestion (Q653971) (← links)
• hiatus hernia (Q727153) (← links)
• chronic renal insufficiency (Q736715) (← links)
• hematochezia (Q1642049) (← links)
• gastric ulcer (Q4003020) (← links)
• Comparative study of 3 drugs (aceglutamide aluminum, zinc acexamate, and magaldrate) in the long-term maintenance treatment (1 year) of peptic ulcer (Q28325543) (← links)
• A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. (Q34570941) (← links)
• Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward. (Q34582024) (← links)
• Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl) (Q34712930) (← links)
• Action of hydrochloric acid on aluminum hydroxide-magnesium hydroxide gels and magaldrate: 27Al NMR and pH-stat studies (Q41507908) (← links)
• A layered lattice antacid with long-term effectiveness. Profile of action and safety exemplified by magaldrate (Q42558768) (← links)
• Bioavailability of a crushed pantoprazole tablet after buffering with sodium hydrogencarbonate or magaldrate relative to the intact enteric coated pantoprazole tablet (Q43645687) (← links)
• [Magaldrate (100 mmol/d) versus ranitidine (300 mg/d). Healing rates of stomach ulcer in a German double-blind study] (Q68918822) (← links)
• Action of hydrochloric acid on aluminum hydroxide-magnesium hydroxide gels and magaldrate: quasi-elastic light scattering studies (Q69573273) (← links)
• Cytoprotective and antiulcer activities of the antacid magaldrate in the rat (Q69734667) (← links)
• Magaldrate and almasilate--complex buffering antacids (Q69892202) (← links)
• Magaldrate compared to ranitidine. The healing rate of stomach ulcer using magaldrate (100 mmol/d) versus ranitidine (300 mg/d) (Q69896059) (← links)
• Effects of magaldrate on circadian profile of gastric juice pH in medical intensive care patients (author's transl) (Q70972568) (← links)
• In vitro evaluation of magaldrate antacid efficacy in the presence of some drugs and its effect on their dissolution rates: Part I (Q73146203) (← links)
• Effect of antacid magaldrate oral suspension on in-vitro and in-vivo availability of indomethacin in dogs (Q73252542) (← links)
• Antiulcer activity and the mechanism of action of magaldrate in gastric ulceration models of rat (Q74168597) (← links)
• Magaldrate stimulates endogenous prostaglandin E2 synthesis in human gastric mucosa in vitro and in vivo (Q78023508) (← links)
• Are 2 tablets of magaldrate at bedtime effective in the therapy of duodenal ulcer? (Q93605919) (← links)
• Wikidata:Database reports/Constraint violations/P2175 (← links | edit)
• Wikidata:Database reports/Constraint violations/P4235 (← links | edit)